Drugs / Bupivacaine HCI
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02762929 | May 2016 → Feb 2017 | — | Heron Therapeutics | Completed | No outcome recorded |
| Phase 2 | NCT02504580 | Jul 2015 → Mar 2017 | — | Heron Therapeutics | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bupivacaine HCI | “Bupivacaine HCI, via injection.” NCT02762929 ↗ |
| Known as | Marcaine | “Bupivacaine HCI (Marcaine) by injection.” NCT02504580 ↗ |
| Route | Other | “Bupivacaine HCI (Marcaine) by injection.” NCT02504580 ↗ |